Interestingly, lactate may act through both HIF (hypoxia-inducible factor)-dependent and HIF-independent mechanisms, and all of them involve the import of lactate by tumor microenvironment cells through the MCT1 transporter and the subsequent inhibition of prolyl hydroxylase. This evidence concerns the gene SLC16A1 and neoplasm.